Adlai Nortye (ANL) Shares Outstanding (Weighted Average) (2022 - 2025)
Adlai Nortye (ANL) reported Shares Outstanding (Weighted Average) of $2000.0 for Q4 2025, little changed year-over-year from $2000.0 in Q4 2024, and down 100.0% on a QoQ basis from $95.9 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $2000.0 in Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $2000.0, changed 0.0% from the prior year.
- Shares Outstanding (Weighted Average) eased to $2000.0 in Q4 2025 per ANL's latest filing, from $95.9 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $95.9 million in Q2 2025 and bottomed at $2000.0 in Q4 2024.
- The 4-year median for Shares Outstanding (Weighted Average) is $12.7 million (2022), against an average of $33.3 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) plunged 99.96%; it then advanced 22.3% in 2025.
- Tracing ANL's Shares Outstanding (Weighted Average) over 4 years: stood at $25.4 million in 2022, then sank by 99.96% to $9000.0 in 2023, then plunged by 77.78% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
- Per Business Quant, the three latest ANL Shares Outstanding (Weighted Average) figures stand at $2000.0 (Q4 2025), $95.9 million (Q2 2025), and $2000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Jun 30, 2025 | 95.86 Mn |
| Dec 31, 2024 | 2,000.00 |
| Jun 30, 2024 | 78.39 Mn |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 25.44 Mn |